Breast Reduction: Who Needs It, What to Expect

Breast reduction is decided from daily life, not appearance first — how much the shoulders, neck, and back hurt, and whether the skin is breaking down. To answer plainly: it is one of the higher-satisfaction breast operations, but it leaves scars, and how much tissue is removed does not, by itself, predict how satisfied you will be. This article covers when reduction is indicated, how the amount and method are chosen, and recovery, satisfaction, and complications. Every clinical figure is linked to a cited study.

1. When reduction is indicated

The first thing checked is not aesthetics but function — the answer shapes the plan:

When several of these coexist, it is assessed as a medical indication.

2. How much is removed, and by what method

Removing 500 g or more per side is generally classed as macromastia; in the U.S. 500 g+ per side is an insurance threshold, and in Korea some insurance may apply when a medical indication is recognised. But the amount removed is not the same as satisfaction: in a meta-analysis of 28 studies, BREAST-Q improvement did not scale with resection weight (Wang et al., Aesthet Surg J, 2023)[1] — a result that questions the practice of gating surgery by grams. What symptoms to relieve matters more than how many grams to remove. The amount and the breastfeeding plan are decided together, and the method follows:

If breastfeeding is planned, a gland-preserving technique is favoured; to minimise the scar, a vertical incision can be considered.

3. Recovery, satisfaction, and complications

Know the scar timeline first — returning to daily life is quick, but the scar takes far longer:

Satisfaction is high — in the same meta-analysis, BREAST-Q breast-satisfaction rose from 22.9 before surgery to 73.0 after, with significant gains in psychosocial, physical, and sexual well-being (Wang et al., 2023).[1] But it is a scarring operation, and both sides should be weighed to avoid regret. Complications include:

Summary

References

  1. Wang AT, Panayi AC, Fischer S, et al. Patient-reported outcomes after reduction mammoplasty using BREAST-Q: a systematic review and meta-analysis. Aesthet Surg J. 2023;43(4):NP231–NP241. doi:10.1093/asj/sjac318.
  2. Dow T, Selman T, Williams J, Bezuhly M. The role of ACE-inhibitors and ARBs in reducing hypertrophic scarring following bilateral breast reduction. J Plast Reconstr Aesthet Surg. 2023;78:1–3. doi:10.1016/j.bjps.2022.11.032.

Medical disclaimer. This article is general information and does not constitute medical diagnosis or treatment advice. Indications, technique, and insurance coverage vary by individual and record; accurate planning is determined through in-person consultation with a board-certified plastic surgeon.

Dr. Kim Uigeon (Board-certified plastic surgeon, Republic of Korea · UNE Plastic Surgery)